168 related articles for article (PubMed ID: 34405290)
1. Preparation, Characterization, and In Vitro/In Vivo Evaluation of 3-O-β-D-Galactosylated Resveratrol-Loaded Polydopamine Nanoparticles.
Wang B; Shan X; Lv S; Zha L; Zhang C; Dong Q; Chen W
AAPS PharmSciTech; 2021 Aug; 22(7):220. PubMed ID: 34405290
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxicity and liver targeting of 3-O-β-D-Galactosylated Resveratrol.
Qian J; Zha L; Wang B; Zhang C; Hong L; Chen W
J Pharm Pharmacol; 2019 Jun; 71(6):929-936. PubMed ID: 30834522
[TBL] [Abstract][Full Text] [Related]
3. In vitro/in vivo evaluation of pH-sensitive Gambogenic acid loaded Zein nanoparticles with polydopamine coating.
Zha L; Qian J; Wang B; Liu H; Zhang C; Dong Q; Chen W; Hong L
Int J Pharm; 2020 Sep; 587():119665. PubMed ID: 32702449
[TBL] [Abstract][Full Text] [Related]
4. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Siu FY; Ye S; Lin H; Li S
Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
[TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
[TBL] [Abstract][Full Text] [Related]
6. A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin.
Zhou Y; Zhu X; Lin S; Zhu C; Wu L; Chen R; Chen Z; Li W
Int J Nanomedicine; 2020; 15():5073-5082. PubMed ID: 32764937
[TBL] [Abstract][Full Text] [Related]
7. Formulation design, optimization and
Hasija R; Chaurasia S; Gupta S
Pharm Dev Technol; 2021 Nov; 26(9):953-966. PubMed ID: 34374616
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles prepared by polysaccharides extracted from Biyang floral mushroom loaded with resveratrol: Characterization, bioactivity and release behavior under in vitro digestion.
Liu K; Liu Y; Lu J; Liu X; Hao L; Yi J
Food Chem; 2023 Nov; 426():136612. PubMed ID: 37348397
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol-loaded nanocarriers: formulation, optimization, characterization and in vitro toxicity on cochlear cells.
Musazzi UM; Youm I; Murowchick JB; Ezoulin MJ; Youan BB
Colloids Surf B Biointerfaces; 2014 Jun; 118():234-42. PubMed ID: 24816150
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and in vitro release of β-galactosidase loaded polyelectrolyte nanoparticles.
Zhang H; Yu H; Mei J; Zhang Y; Deng Z
Int J Biol Macromol; 2018 Aug; 115():1-9. PubMed ID: 29649531
[TBL] [Abstract][Full Text] [Related]
11. Folate-conjugated human serum albumin-encapsulated resveratrol nanoparticles: preparation, characterization, bioavailability and targeting of liver tumors.
Lian B; Wu M; Feng Z; Deng Y; Zhong C; Zhao X
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):154-165. PubMed ID: 30686050
[TBL] [Abstract][Full Text] [Related]
12. Optimization on biodistribution and antitumor activity of tripterine using polymeric nanoparticles through RES saturation.
Yin J; Wang P; Yin Y; Hou Y; Song X
Drug Deliv; 2017 Nov; 24(1):1891-1897. PubMed ID: 29191042
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles improved resveratrol brain delivery and its therapeutic efficacy against intracerebral hemorrhage.
Mo Y; Duan L; Yang Y; Liu W; Zhang Y; Zhou L; Su S; Lo PC; Cai J; Gao L; Liu Q; Chen X; Yang C; Wang Q; Chen T
Nanoscale; 2021 Feb; 13(6):3827-3840. PubMed ID: 33565555
[TBL] [Abstract][Full Text] [Related]
14. Surface modification of doxorubicin-loaded nanoparticles based on polydopamine with pH-sensitive property for tumor targeting therapy.
Bi D; Zhao L; Yu R; Li H; Guo Y; Wang X; Han M
Drug Deliv; 2018 Nov; 25(1):564-575. PubMed ID: 29457518
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and brain targeting of
Katekar R; Thombre G; Riyazuddin M; Husain A; Rani H; Praveena KS; Gayen JR
Pharm Dev Technol; 2020 Mar; 25(3):300-307. PubMed ID: 31609159
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin.
Guo H; Zhang D; Li C; Jia L; Liu G; Hao L; Zheng D; Shen J; Li T; Guo Y; Zhang Q
Int J Pharm; 2013 Dec; 458(1):31-8. PubMed ID: 24140544
[TBL] [Abstract][Full Text] [Related]
18. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles.
Zu Y; Zhang Y; Wang W; Zhao X; Han X; Wang K; Ge Y
Drug Deliv; 2016; 23(3):981-91. PubMed ID: 24918466
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite/Zein nano-drug delivery system for doxorubicin hydrochloride.
Zha L; Wang B; Qian J; Fletcher B; Zhang C; Dong Q; Chen W; Hong L
J Pharm Pharmacol; 2020 Apr; 72(4):496-506. PubMed ID: 31975457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
